Jamie S Hirsch
Overview
Explore the profile of Jamie S Hirsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
7059
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adhikari A, Haghamad A, Huang X, Fishbein J, Vaidean G, Hirsch J, et al.
J Clin Lipidol
. 2025 Mar;
PMID: 40044468
Lipid goal attainment remains suboptimal due to patient, provider, and system level factors. We aimed to assess whether updated, guideline-based lipid reporting and clinical decision support was associated with different...
2.
Kim E, Coppa K, Abrahams S, Hanchate A, Mohan S, Lesser M, et al.
PLoS One
. 2025 Jan;
20(1):e0316892.
PMID: 39752456
Transitional care management (TCM) visits have been shown to reduce 30-day readmissions, but it is unclear whether the decrease arises from the TCM visit itself or from clinic-level changes to...
3.
Gupta S, Glezerman I, Hirsch J, Wells S, Chen K, Seitter R, et al.
Nephrol Dial Transplant
. 2024 Oct;
40(2):405-408.
PMID: 39415423
No abstract available.
4.
Hirsch J, Danna S, Desai N, Gluckman T, Jhamb M, Newlin K, et al.
J Clin Med
. 2024 Apr;
13(5).
PMID: 38592013
Background: Approximately 37 million individuals in the United States (US) have chronic kidney disease (CKD). Patients with CKD have a substantial morbidity and mortality, which contributes to a huge economic...
5.
Gupta S, Glezerman I, Hirsch J, Chen K, Devaraj N, Wells S, et al.
BMJ
. 2024 Mar;
384:e077169.
PMID: 38538012
Objective: To develop and externally validate a prediction model for severe cisplatin associated acute kidney injury (CP-AKI). Design: Multicenter cohort study. Setting: Six geographically diverse major academic cancer centers across...
6.
Ho M, Levy T, Koulas I, Founta K, Coppa K, Hirsch J, et al.
Int J Med Inform
. 2023 Nov;
181:105286.
PMID: 37956643
Background: COVID-19 is a challenging disease to characterize given its wide-ranging heterogeneous symptomatology. Several studies have attempted to extract clinical phenotypes but often relied on data from small patient cohorts,...
7.
Hirsh B, Hirsch J, Hmoud H, Weintraub S, Cha A, Lesser M, et al.
Am J Prev Cardiol
. 2023 Oct;
16:100608.
PMID: 37822579
Objective: Despite demonstrating improvements in cardiovascular disease, kidney disease, and survival outcomes, guideline-directed antihyperglycemic medications such as sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like-peptide-1 receptor agonists (GLP1-RA), are underutilized. Many...
8.
Ostrominski J, Arnold S, Butler J, Fonarow G, Hirsch J, Palli S, et al.
JAMA Cardiol
. 2023 Sep;
8(11):1050-1060.
PMID: 37755728
Importance: Individually, cardiac, renal, and metabolic (CRM) conditions are common and leading causes of death, disability, and health care-associated costs. However, the frequency with which CRM conditions coexist has not...
9.
Hirsch J, Jhaveri K, Abate M, Molmenti E, Coppa K, Nair V
Clin Nephrol
. 2023 Jun;
100(3):140-142.
PMID: 37366556
No abstract available.
10.
Brar R, Friedman M, Dacosta N, Rimar A, Cohen J, Liberman T, et al.
AMIA Annu Symp Proc
. 2023 May;
2022:269-278.
PMID: 37128398
Early identification of advanced illness patients within an inpatient population is essential in order to establish the patient's goals of care. Having goals of care conversations enables hospital patients to...